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ABSTRACT
Thymic stromal lymphopoietin (TSLP) has been recently implicated as a key molecule for initiating allergic in-
flammation at the epithelial cell-dendritic cell (DC) interface. In humans, aberrant TSLP expression is observed
in allergic tissues, such as lesional skins of atopic dermatitis, lungs of asthmatics, nasal mucosa of atopic rhini-
tis and nasal polyps, and ocular surface of allergic keratoconjunctivitis. TSLP is produced predominantly by
damaged epithelial cells and stimulates myeloid DCs (mDCs). TSLP-activated mDCs can promote the differen-
tiation of naïve CD4+ T cells into a Th2 phenotype and the expansion of CD4+ Th2 memory cells in a unique
manner dependent on OX40L, one of the tumor necrosis factor superfamily members with Th2-promoting func-
tion, and lack of production of IL-12. From a genetic point of view, multiple genome-wide association studies
have repeatedly identified the TSLP gene as one of the loci associated with susceptibility to allergic diseases.
Thus, TSLP is a rational therapeutic target for the treatment of allergic disorders. Elucidating the mechanisms
that regulate TSLP expression and the effects of TSLP on orchestrating the immune response toward a Th2
phenotype is essential for developing anti-TSLP therapy.
KEY WORDS
allergic inflammation, dendritic cells (DCs), OX40L, Th2 cells, thymic stromal lymphopoietin (TSLP)
INTRODUCTION
The prevalence of allergic diseases, such as atopic
dermatitis, bronchial asthma, and allergic rhinitis,
has increased.1 These allergic diseases are the result
of a complex immunological effector system that in-
cludes T cells, B cells, eosinophils, basophils, and
mast cells. Recent progress in understanding the
mechanism of these allergic diseases has highlighted
the integral role of dendritic cells (DCs) in the cellu-
lar cascade responsible for allergic inflammation
through the induction of inflammatory T helper type
2 (Th2) cells.2 DCs are considered the most effective
cell population that induces distinct immune re-
sponses to different pathogens, which is often called
“functional plasticity”.3,4 For instance, DCs induce in-
terferon (IFN)-γ-secreting Th1-cells with high cyto-
toxicity in response to viral and intracellular bacterial
infection, whereas the same cells induce Th2 cells
that secret interleukin (IL)-4, IL-5, and IL-13, which
are required for induction of IgE, hypersecretion of
mucus, and recruitment of eosinophils in response to
parasite infection. Allergy is a state in which the host
overreacts to otherwise innocuous antigens (aller-
gens) by inducing Th2-type inflammation.
Recently, TSLP, IL-25, and IL-33, all epithelial cell-
derived cytokines, have been shown to play impor-
tant roles in the initiation and maintenance of allergic
Allergology International. 2012;61:35-43
REVIEW ARTICLE
1First Department of Internal Medicine, Kansai Medical University,
Osaka, 3Division of Medical Biochemistry, Department of Bio-
molecular Sciences, Saga Medical School, Saga, Japan and 2De-
partment of Immunology, Center for Cancer Immunology Re-
search, The University of Texas MD Anderson Cancer Center,
Houston, TX, USA.
Conflict of interest: No potential conflict of interest was disclosed.
Correspondence: Kazuhiko Arima, Department of Biomolecular
Sciences, Saga Medical School, 5−1−1 Nabeshima, Saga 849−
8501, Japan.
Email: arimaka@cc.saga−u.ac.jp
Received 25 September 2011.
2012 Japanese Society of Allergology
DOI: 10.2332allergolint.11-RAI-0376
Ito T et al.
36 Allergology International Vol 61, No1, 2012 www.jsaweb.jp
Fig.　1　TSLP and TSLP receptor structure. The functional 
TSLP receptor complex consists of TSLPR and IL-7Rα 
chains. The extracellular portions of these chains comprise a 
TSLP-binding unit. The intracellular portions of both receptor 
chains contain membrane proximal Box1 domains and tyro-
sine residues that are involved in signal transduction. TSLP 
stimulation induces activation of several signal transduction 
pathways including STAT3 and STAT5. However, this acti-
vation alone cannot explain the unique function of TSLP in 
human dendritic cell (DC) activation.
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responses in the epithelial surfaces of skin, airway, or
gastrointestinal tract.5 Of these cytokines, TSLP rep-
resents a key link between epithelial cells and DCs at
the interface of allergic inflammation by participating
in the programming of DC-mediated Th2 polariza-
tion.6 TSLP is produced mainly by damaged epithelial
cells and conditions the immune system to induce
Th2-type immune responses.6,7 This TSLP-mediated
epithelia-immune system axis was shown to be pro-
tective against helminth infection.8 However, if other
epithelial cells such as keratinocytes and bronchial
epithelial cells are part of this axis, it becomes harm-
ful by enhancing Th2-type immunity. Multiple lines of
evidence, mainly from mouse experiments, suggest
that TSLP acts on several hematopoietic cell types
such as DCs, mast cells, NKT cells, eosinophils and
basophils to induce allergic inflammation.6,9 However
in humans, DCs are the major cell type on which
TSLP acts. In this review article, we first summarize
the documented association between TSLP and hu-
man allergic disorders, and then we describe the cel-
lular and molecular mechanisms by which TSLP acti-
vates DCs and induces allergic inflammation.
TSLP AND TSLP RECEPTOR
TSLP is an IL-7-like, four-helix bundle cytokine that
was first isolated from a mouse thymic stromal cell
line and shown to support lymphocyte development
in the absence of IL-7.10,11 The human TSLP (hTSLP)
was isolated using a database search method,12,13 and
the hTSLP gene was mapped to chromosome 5q22.1,
which is near the Th2 cytokine gene cluster loci
5q23-32. Although epithelial cells appear to be the
major source of TSLP,7,13 other cell types such as fi-
broblasts, smooth muscle cells, mast cells and baso-
phils have been shown to have the potential to pro-
duce TSLP as well.7,14
The TSLP receptor is a heterodimeric receptor
complex consisting of the TSLPR and the IL-7Rα
chains13,15-17 (Fig. 1). The TSLPR chain is most
closely related to the IL-2Rγ chain (γc). The extracel-
lular portion of the TSLPR chain likely comprises a
cytokine recognition homology domain. The intracel-
lular portion of the TSLPR chain harbors a Box 1 mo-
tif and a single tyrosine residue, both are involved in
signal transduction upon TSLP binding.18,19 TSLP
binds to the TSLPR chain with a low affinity, but does
not show any affinity to the IL-7Rα chain alone.16,17
However, the combination of TSLPR and IL-7Rα
chains results in high-affinity binding to TSLP and
transduces, at least, activation of signal transducer
and activator of transcription (STAT) 5 upon TSLP
binding.13,15
ASSOCIATION OF TSLP WITH HUMAN AL-
LERGIC DISORDERS
Since 2003, several lines of evidence from mouse in
vivo genetic data have solidified the concept that
TSLP is a proallergic cytokine that plays a critical role
in allergic inflammatory responses.6 At the same
time, exaggerated TSLP production has been ob-
served in multiple human allergic disorders such as
atopic dermatitis, bronchial asthma, allergic rhinitis,
and eosinophilic esophagitis. Moreover, recent large-
scale human genetic studies have identified the TSLP
gene locus as one of the allergy-susceptibility loci.
ATOPIC DERMATITIS
The link between TSLP and allergic disorders was
first suggested just after the molecular cloning of hu-
man TSLP. Soumelis et al. demonstrated that the epi-
dermis of lesional skin in patients with atopic derma-
titis had higher TSLP expression than that of unin-
volved skin or skin from patients with non-allergic
dermatitis.7 Interestingly, TSLP expression in pa-
tients with atopic dermatitis was associated with the
migration of Langerhans cells, which expressed
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abundant levels of the activation marker DC-LAMP,
to the dermis. This suggests that TSLP may contrib-
ute to the activation of these cells and promote their
migration to the draining lymph nodes, where they
prime T-cell responses. A more recent study showed
that TSLP protein expression was also upregulated in
skin lesions from patients with Netherton syndrome,
a severe, genetic skin disease with a constant atopic
manifestation caused by mutations in the SPINK5
gene, illuminating a common role of TSLP in the
pathogenesis of dermatitis with atopic characteris-
tics.20 Multiple studies have investigated a possible
correlation between serum TSLP levels and atopic
dermatitis. In adults, serum TSLP levels were not in-
creased in patients with atopic dermatitis,21,22 while
one report showed that serum TSLP levels in chil-
dren with atopic dermatitis were significantly higher
than those in normal controls.23 However, serum
TSLP levels did not significantly correlate with dis-
ease severity, blood eosinophil counts and serum to-
tal IgE levels, suggesting that TSLP does not mainly
enter the blood circulation. This lack of quantitative
correlation was also observed in an earlier study in
which TSLP expression levels in lesional epidermis
did not correlate with the degree of disease severity
or serum IgE levels.7 TSLP produced within the epi-
dermis might contribute in situ to the initiation of dis-
ease but not its progression. With regard to this
point, Wang et al. suggested that another epithelial
cell-derived cytokine, IL-25, plays a supportive func-
tional role in the maintenance of adaptive Th2 mem-
ory cells induced by TSLP-activated DCs (TSLP-
DCs), leading to the progression of chronic allergic
disease24 (Fig. 2).
BRONCHIAL ASTHMA
Ying et al. showed by in situ hybridization that TSLP
mRNA expression was increased in asthmatic air-
ways and correlated with both the expression of Th2-
attracting chemokines and disease severity, which
provided the first link between TSLP and human
asthma.25 More recently, it was demonstrated that
TSLP protein expression in bronchoalveolar lavage
fluids of patients with allergic asthma was indeed ele-
vated than in fluids from healthy controls or non-
allergic asthmatics.26 However, there is no report re-
garding serum TSLP levels in asthmatics. Epithelial
cells are considered to be the main source of TSLP.6,9
In the lungs, the production of TSLP by bronchial epi-
thelial cells can be enhanced in response to a wide va-
riety of allergens and viral infections. This may par-
ticularly explain why respiratory viral infections exac-
erbate the symptoms of bronchial asthma.27 Aug-
mented TSLP expression may contribute to the con-
ditioning of the response by the local environment to
incoming allergens.
ALLERGIC RHINITIS AND NASAL POLYPS
Allergic rhinitis and nasal polyps are chronic inflam-
matory diseases of the upper airways often associated
with asthma and are characterized by increased se-
rum IgE and numbers of eosinophils, Th2 cells, gob-
let cells, and mast cells. TSLP expression was aug-
mented in the nasal mucosa of allergic rhinitis pa-
tients, and TSLP production correlated well with se-
verity of the disease and numbers of eosinophils.28,29
The number of TSLP-expressing cells was signifi-
cantly greater in the nasal mucosa of allergic rhinitis
patients than that of non-allergic rhinitis patients. Fur-
thermore, it was reported that expression of TSLP
and Th2-recruiting chemokines, such as thymus- and
activation-regulated chemokine (TARCCCL17) and
macrophage-derived chemokines (MDCCCL22),
was markedly higher in nasal polyps than allergic na-
sal mucosa.30 Importantly, a strong correlation ex-
isted between the number of TSLP-expressing cells
in nasal polyps and eosinophil counts and IgE levels.
Interestingly, an infiltration of IL-4+TNF+ CD4+ T cells
was found in the nasal polyposis mucosa of patients
with allergic rhinitis, whereas an infiltration of
IFN-γ+TNF+ CD4+ T cells was found in the same types
of sample from patients with non-allergic rhinitis.31
These observations are consistent with a proposed
scenario by which TSLP induces TNF+ inflammatory
Th2-type immune response described below.
KERATOCONJUNCTIVITIS
Similar to other types of epithelial cells, human cor-
neal epithelial cells were shown to be capable of pro-
ducing TSLP in response to an array of Toll-like re-
ceptor (TLR) ligands or proinflammatory cytokines.32
Atopic keratoconjunctivitis and vernal keratoconjunc-
tivitis are types of severe, chronic allergic inflamma-
tion at the ocular surface in which giant papillae for-
mation is frequently observed and is characterized by
local infiltration of eosinophils, Th2 cells, and mast
cells. The giant papillae tissues obtained from pa-
tients with keratoconjunctivitis had in vivo expression
of TSLP mRNA and protein in the epithelium,
whereas control conjunctivae specimens did not.33
GENETIC ASSOCIATION OF TSLP GENE AND
ALLERGIC DISORDERS
Besides the in vivo TSLP expression data described
above, there is another line of evidence suggesting
that TSLP plays some roles in human allergic disor-
ders. First, multiple genome-wide studies have found
that polymorphisms near or within the TSLP gene
were associated with various aspects of allergic in-
flammation such as IgE levels,34 eosinophil num-
bers,35 pediatric eosinophilic esophagitis,36 and bron-
chial asthma.37,38 Importantly, two large meta-
analyses of asthma genome-wide association studies
involving European and diverse US populations simi-
larly highlighted a robust association of four loci,
Ito T et al.
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Fig.　2　Schematic illustration of the TSLP-mediated allergic infl ammation. Insults from allergens or certain pathogens 
trigger the aberrant expression of TSLP by epithelial cells exposed to the environment (such as skin keratinocytes and 
airway epithelium), mast cells and basophils. TSLP in turn activates DCs residing in the epithelium to migrate to draining 
lymph nodes, where they prime naïve T cells. During this process, TSLP-activated DCs (TSLP-DCs) preferentially ex-
press OX40L without IL-12 production and concomitantly produce chemokines including TARC/CCL17, MDC/CCL22, 
and eotaxin-2/CCL24, which function as chemoattractants for Th2 cells and eosinophils. DC-expressing OX40L strongly 
primes naïve CD4+ T cells to differentiate into infl ammatory Th2 cells with the capacity to produce IL-4, IL-5 and IL-13 
and TNF, but little or no IL-10. OX40L is the DC-derived trigger to induce the generation of such TNF++ IL-10− infl amma-
tory Th2 cells, while IL-4 derived from the developing Th2 cells is an autocrine enhancer of the infl ammatory Th2 re-
sponse. Furthermore, OX40L on TSLP-DCs and IL-25 from epithelia or infi ltrated eosinophils and basophils work syner-
gistically in maintaining the memory Th2 cell response by expansion and further enhancement of Th2 cytokine 
production. Infl ammatory Th2 cytokines eventually initiate allergic responses by activation of B cells, mast cells, eosino-
phils, basophils, and airway epithelium.
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17q21 locus, IL1RL1IL18R, IL33, and TSLP, with
asthma.37 These results suggest that epithelial cell-
derived factors (IL-33 and TSLP; IL1RL1 encodes an
IL-33 receptor) play important roles in the heritable
traits of asthma pathogenesis. Furthermore, several
“candidate gene approaches” have been taken to
identify the genes associated with susceptibility to al-
lergic diseases and have found genetic links between
polymorphisms near or within the TSLP gene and
atopic dermatitis,39 bronchial asthma,40,41 and allergic
rhinitis.42 Functionally, one of the polymorphisms in
the regulatory element of the TSLP gene creates a
binding site for activating protein-1 (AP-1) and affects
the transcriptional efficiency of TSLP induced by
stimulation with double-stranded RNA, which mimics
viral infection, in bronchial epithelial cells, indicating
that a genetic factor could affect environmental-
driven TSLP production.43 A genetic association be-
tween the TSLPR gene and eosinophilic esophagitis
was also reported, substantiating that the TSLP
TSLPR system is an important disease-susceptible
factor for eosinophilic esophagitis, a chronic Th2-
associated inflammatory disease.44
TSLP-ACTIVATED DCs MEDIATE Th2 IN-
FLAMMATION THROUGH OX40L
TSLP is a key cytokine that initiates DC-mediated
Th2 immune response in the allergic cascade (Fig.
2). TSLP-DCs can induce naïve T cells to differentiate
into a new type of effector Th2 cells producing IL-4,
IL-5, IL-13, and TNF, but not IL-10.7 Historically, Th2
cells are defined as effector T cells with the capacity
to produce IL-4, IL-5, IL-13, and IL-10.45,46 However,
IL-10 is recognized as an anti-inflammatory cytokine
that suppresses allergic inflammation.47-49 Many stud-
ies have demonstrated that such conventional Th2
cells are not involved in allergic inflammation.50-52 In
contrast to IL-10, TNF has been implicated in Th2
Role of TSLP in Human Allergic Disorders
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cell-mediated allergic diseases.53-56 In this context,
the TSLP-DC-induced TNF-highly positive and IL-10-
negative “inflammatory Th2” cells most likely repre-
sent the pathogenic Th2 cells that cause allergic in-
flammation.57
OX40 ligand (OX40L) was identified as the critical
downstream mediator of TSLP-DCs that induces in-
flammatory Th2 cell responses.57 It belongs to the
TNF superfamily that has been implicated in the in-
itiation of Th2 cell responses.58-60 In contrast to TLR
ligands such as poly (I:C) and LPS, TSLP stimulates
human myeloid DCs to upregulate OX40L preferen-
tially.57 Blockade of OX40L using neutralizing anti-
bodies to OX40L dramatically inhibited production of
IL-4, IL-5, IL-13, and TNF and promoted IL-10 produc-
tion by CD4+ T cells primed by TSLP-DCs.57 In addi-
tion, recombinant OX40L-transfected cells, like TSLP-
DCs, strongly primed naïve CD4+ T cells to produce
IL-4, IL-5, IL-13 and TNF, but little IL-10. These data
confirm that OX40L is the original trigger of TSLP-
DCs to induce the generation of TNF++IL-10− inflam-
matory Th2 cells. On a transcriptional basis, it was
determined that OX40L expressed by TSLP-DCs in-
duced the expression of GATA-3 in T cells, further
supporting their critical roles in Th2 polarization.57
In addition to preferential induction of OX40L ex-
pression, another specific feature of TSLP-DCs is a
lack of proinflammatory cytokine production includ-
ing IL-12 as well as type I IFNs, both of which are fac-
tors required for Th1 differentiation.4,7 The OX40L-
mediated inflammatory Th2 cell differentiation de-
pends critically on the absence of IL-12, as IL-12
shows dominant effect over OX40L in Th cell differ-
entiation.57 Thus, the development of inflammatory
Th2 cells leading to allergic inflammation requires
two immunological conditions, an expression of
OX40L and an absence of IL-12.
Although IL-4 is the key Th2-polarizing signal,4,46,61
human DCs activated by TSLP or other stimuli have
no capacity to produce IL-4,7,57 Thus, IL-4 is not the
DC-derived original trigger of Th2 responses. How-
ever, blockade of IL-4 using a neutralizing antibody to
IL-4 in a coculture system of TSLP-DCs and naïve T
cells demonstrated that IL-4 contributed to the gen-
eration of Th2 cells induced by TSLP-DCs but had no
effect on TNF or IL-10 production in the Th2 cells.57
These findings suggest that IL-4 derived from the de-
veloping Th2 cells is an autocrine enhancer, and DC-
derived OX40L and Th2 cell-derived IL-4 could work
synergistically in driving Th2 cell responses.
Recent studies have suggested that memory Th2
cells are the principal cell population responsible for
the maintenance of chronic allergic inflammation and
the relapse of allergic inflammation upon re-exposure
to allergens.62-65 Elevated TSLP expression in in-
flamed keratinocytes of skin samples from patients
with atopic dermatitis,7 together with the findings
that CRTH2+ memory Th2 cells had infiltrated the
dermis of legional skin and were present at increased
frequency in the blood of atopic dermatitis patients66
indicate the pathophysiological importance of the link
between TSLP and memory Th2 cells in allergic dis-
eases (Fig. 2). Also in regard to this point, TSLP-DCs
play a role in the homeostatic expansion of allergen-
specific Th2 memory cells and in the further polariza-
tion of the Th2 phenotypes, contributing to the main-
tenance of chronic allergic inflammation.67 OX40L on
TSLP-DCs also aids this process and enhances DC
survival by allowing formation of prolonged DC-T cell
conjugates.67 Moreover, TSLP equips DCs with the
capacity to produce a variety of chemokines such as
TARCCCL17, MDCCCL22, I-309CCL1, eotaxin-2
CCL24 as well as IL-8CXCL8,7,57 which function as
chemoattractants for Th2 cells, eosinophils, and neu-
trophils, contributing to aggravation or maintenance
of chronic allergic inflammation. In this process, IL-
25, another epithelial cell-derived cytokine aberrantly
expressed in atopic dermatitis skin lesion and asth-
matic lung tissues, enhances memory Th2 cell expan-
sion and function induced by TSLP-DCs24 (Fig. 2).
While TSLP is further produced by mast cells and ba-
sophils,7,14,68 IL-25 is further produced by eosinophils
and basophils.24 Thus, epithelial cell-derived cytoki-
nes collaboratively conduct the Th2 cell-mediated in-
flammation that tailors the activation of mast cells and
eosinophils in the development and maintenance of
allergic disorders.
TSLP SIGNAL TRANSDUCTION IN HUMAN
DCs
Upon binding to TSLP, the TSLP receptor complex
generates intracellular signaling. Earlier studies dem-
onstrated that TSLP induces STAT3 and STAT5 phos-
phorylation, resulting in transcription of the STAT-
responsive genes, such as CIS15 13,69 (Fig. 1). How-
ever, the precise kinase responsible for TSLP-
mediated STAT phosphorylation has long remained
controversial.15,18,69 Moreover, the pleiotropic func-
tion of TSLP in human myeloid DCs apparently can-
not be explained by activation of STAT3 and STAT5
alone, which is ubiquitous in many cytokine signaling
pathways. Thus, we performed a large-scale isolation
of human primary DCs to study intracellular signal-
ing triggered by TSLP70 (Fig. 3). In myeloid DCs,
hTSLP induced robust and sustained (-1 h) phospho-
rylation of JAK1 and JAK2, while hIL-7 induced only
transient (-5 min) phosphorylation of JAK1. Conse-
quently, hTSLP induced broad and sustained (>2 h)
phosphorylation of STAT1, STAT3, STAT4, STAT5,
and STAT6. Direct STAT6 activation by TSLP
seemed to be the responsible mechanism for induc-
ing TARCCCL17 production.70 In addition, hTSLP
induceed phosphorylation of AKT and the MAPKs
ERK and JNK, all are sensitive to JAK inhibitors.
hTSLP also induced a slow but robust NF-κB activa-
tion, as revealed by sustained nuclear localization of
Ito T et al.
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Fig.　3　Distinct signal codes generate the functional plastic-
ity of human myeloid DCs (mDCs). DC activators such as 
TLR ligands and CD40L induce mDC maturation and IL-12 
production, thus promoting Th1 responses. This IL-12 pro-
duction is granted by co-expression and activation of STAT4 
and IRF8. By contrast, TSLP induces mDC maturation that is 
uncoupled from IL-12 production due to lack of induction of 
protein expression of STAT4 and IRF8. TSLP robustly acti-
vates other STATs including STAT6, which leads to produc-
tion of TARC/CCL17, a Th2-attracting chemokine. Further-
more, TSLP induces OX40L expression by mDCs owing to 
unique activation of the NF-κB pathway. Consequently, 
TSLP-activated mDCs induce Th2 responses. TSLP also ac-
tivates PI3K-AKT and some MAPK pathways, whose func-
tions remain elusive.
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How is OX40L selectively upregulated by TSLP-
DCs? The promoter region of OX40L has two poten-
tial NF-κB binding elements. We found that TSLP in-
duced a predominant and persistent nuclear translo-
cation of p50, an NF-κB molecule, which is not pro-
longed when induced by CD40L or TLR ligands. In-
deed, the OX40L promoter preferentially bound
p50.70 In a promoter-reporter assay, we also demon-
strated that p50 plus RelB activated the OX40L pro-
moter. These data suggest that predominant p50 acti-
vation triggered by TSLP is the determinant for selec-
tive upregulation of OX40L as described previously.
Why TSLP-mediated DC maturation is uncoupled
from IL-12 production, also as described above, was
another critical issue to be addressed because most
DC activators, such as CD40L and TLR ligands, in-
duce both DC maturation and IL-12 production to in-
duce Th1 responses.3 Unlike the DC activators capa-
ble of inducing expression of both STAT4 and inter-
feron regulatory factor (IRF) 8 that are required for
IL-12 production, TSLP simply fails to induce protein
expression of these transcription factors. It is of great
interest that TSLP has the capacity to activate STAT6,
a transcription factor involved in a Th2 response, but
not STAT4 in DCs.70 In T helper cell differentiation,
STAT4 and STAT6 show the opposite capacity to pro-
mote Th1- versus Th2-type immune responses, re-
spectively, functioning within T cells. In addition,
STAT4 critically functions also in DCs for a Th1 re-
sponse.71 Our study suggests that STAT6 functions
not only in T cells, but also in DCs to shape Th2-type
immune responses. Taken together, TSLP programs
DCs to induce a Th2 response through selective acti-
vation and inactivation of multiple signaling path-
ways, forming a unique signal code.
FUTURE PERSPECTIVES
TSLP expression in epithelia closely links the initia-
tion and maintenance of inflammatory Th2 cell re-
sponses to its unique DC activation capacity. Further-
more, OX40L expression by TSLP-activated DCs ap-
pears to be a key pathway leading to allergic inflam-
mation. Thus, the TSLP-OX40L axis represents a po-
tential molecular target against allergic disorders.
Studies using neutralizing antibody to OX40L or
OX40L-deficient mice have demonstrated the impor-
tance of OX40-OX40L interaction for triggering Th2
cell immune responses leading to allergic inflamma-
tion in vivo.72-75 Particularly, Seshasayee et al. demon-
strated that treatment with OX40L-neutralizing anti-
bodies inhibited antigen-driven Th2 immune re-
sponses, eosinophil infiltration, and IgE production
induced by TSLP in mice and rhesus monkeys.75 This
strongly suggests that, also in vivo, TSLP-induced
OX40L appears to be a critical mediator of allergic in-
flammation.
Two adjuvants have been reported to alter the abil-
ity of TSLP to induce the pathogenic inflammatory
Th2 cell responses in vitro. One is Bacillus Calmette-
Guérin (BCG), an attenuated derivative of a virulent
strain of Mycobacterium bovis, and the other is imida-
zoquinoline, a specific ligand for TLR7 and TLR8,76
that is used to topically treat viral-mediated skin dis-
eases by cream formulation. BCG and imidazoquino-
line serve as strong immune adjuvants leading to a
Th1 response via maturation of DCs.77-79 Both agents
could function as potent inhibitors of OX40L expres-
sion on human DCs, while they induce IL-12 produc-
tion by DCs, even in the presence of TSLP.80,81 As a
result, they could cancel the DC-mediated Th2-
permissive condition and in turn induce the genera-
tion of IL-10+IFN-γ+ regulatory Th1 cells.80,81 This
type of Th1-like T cells has been reported to possess
the ability to inhibit airway hyperresponsiveness.82
Moreover, imidazoquinoline can block the functional
characteristics of CRTH2+ CD4+ Th2 memory cells
that are expanded and maintained by TSLP-DCs.81 In
terms of signal transduction of TSLP in DCs, a JAK
inhibitor clearly shut down the TSLP-dependent sig-
nals.70 Thus, using a JAK inhibitor for treatment of al-
lergic diseases proposed recently83 might also
dampen the TSLP signal transduction, leading to alle-
Role of TSLP in Human Allergic Disorders
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viation of disease symptoms.
In summary, TSLPOX40L blockade is an attrac-
tive therapeutic approach for the treatment of severe
allergic diseases. The use of drugs to treat allergic
disorders has historically focused on the effector
phase of the allergic immune cascade including acti-
vation of T cells, mast cells, and eosinophils. The
newly emergent concept to target TSLP, DCs, andor
OX40L as key players at the initiation phase of the al-
lergic immune cascade is novel and thus might pave
the way for the development of new treatment for al-
lergic disorders.
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